Antigenic variation is a key mechanism by which pathogens evade the immune system. New research has shown how trypanosomes ...
Shah and colleagues take advantage of the presence of maternal and somatic ribosomes in zebrafish and confirm their differential expression during development. The authors convincingly show that ...
BACKGROUND: Despite the high morbidity and mortality of heart failure with preserved ejection fraction (HFpEF), treatment ...
An international team of scientists has now molecularly decoded the differentiation pathways of human blood stem cells into ...
11d
News-Medical.Net on MSNA safer and more affordable polio vaccine could soon be a realityA more affordable, lower-risk polio vaccine is on the horizon, research led by the University of Leeds has found.
Every second, an adult generates around five million new blood cells to replace aging or dying ones, making the blood system a highly regenerative ...
1d
Study Finds on MSNFat and the First Responders: How Poor Diet Cripples Infection-Fighting CellsAccording to new findings from University of Michigan scientists, eating too much fat could seriously hobble your immune ...
Protalix saw record revenue growth in 2024, driven by increased sales to Chiesi, Pfizer, and Brazil. The company aims to start a Phase 2 trial for PRX-115 in 2025.
5d
Study Finds on MSNWhen Good Cells Turn Bad: Scientists Discover Why Psoriasis Won’t Go AwayDiscover how psoriasis affects immune function and the role of SSAT1 in this chronic skin condition. Learn more now.
Protalix Biotherapeutics (PLX) has gained investor’s attention, and reported a record revenue increase in its fiscal year 2024, primarily due ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results